ESR1 and breast carcinoma: First, we examined a panel of eight breast cancer cell lines, comprising both ER+ve (MCF-7, T-47D, ZR-75-1) and ER-ve (BT-20, BT-549, MDA-MB-231, MDA-MB-436, and MDA-MB-453) cell lines.